NEWS

Filter

September 8, 2026

Canopy Growth Broadens Australian Medical Cannabis Portfolio with New Formats and Formulations

Canopy Growth Broadens Australia Medical Cannabis Portfolio with New Formats and Formulations
Read More

August 17, 2026

Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now

Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the Company has mailed
Read More

August 14, 2026

Poland drives Canopy’s international revenue

Every Canopy Growth business grew in Q1 FY27 - our CEO Luc Mongeau explains why on BNN Bloomberg.
Read More

August 14, 2026

Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows

Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that its Kincardine, Ontario cultivation facility (“Kincardine”) has received renewed European Union Good Manufacturing Practice
Read More

August 10, 2026

Canopy sees growing revenue, declining losses in Q1 2027

Canopy sees growing revenue, declining losses in Q1 2027 - Stratcann | August 7, 2026
Read More

August 7, 2026

Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses

Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses
Read More

July 24, 2026

Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026

SMITHS FALLS, ON – July 24, 2026 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) will release its financial results for the first quarter fiscal year 2027 ended June 30, 2026 before financial markets open on August 7, 2026.
Read More

July 21, 2026

Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference

SMITHS FALLS, ON – July 21, 2026 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) announced it will be participating at the Canaccord Genuity Growth Conference in August 2026.
Read More

June 16, 2026

Medical cannabis: the driving force behind Canopy Growth’s recovery

By Aurélien BERNARD Canadian cannabis producer Canopy Growth announced a significant improvement in its financial results for the fourth quarter of fiscal year 2026, driven by strong growth in both the medical cannabis sector and its international operations. These results suggest that the restructuring efforts the company has been undertaking for several years may finally be starting to pay off.
Read More

June 16, 2026

Canopy’s Turnaround Continues (Video)

Watch Luc Mongeau, CEO of Canopy Growth discuss the company’s fiscal Q4 and full-year 2026 earnings.
Read More

June 15, 2026

Canopy logs 68% year-over-year revenue growth in international segment (Video)

Luc Mongeau, CEO of Canopy Growth, joins BNN Bloomberg to discuss the company's Q4 earnings as well as the outlook for the cannabis industry.
Read More

June 15, 2026

Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis

Full-year 2026 growth driven by net revenue increases of 20% in Canada adult-use cannabis and 18% in Canada medical Completed acquisition of MTL Cannabis, positioning Canopy Growth as Canada’s leading medical cannabis company by revenue Ended the fiscal year with $131.3M of net cash following strategic recapitalization completed in January 2026 Strategic decisions and financial
Read More
Scroll to Top